ClinicalTrials.Veeva

Menu

Characteristics of Neonatal Covid-19 in Turkey

R

Recep Tayyip Erdogan University Training and Research Hospital

Status

Unknown

Conditions

COVID-19
Healthy
Neonatal Disease

Study type

Observational

Funder types

Other

Identifiers

NCT04401540
NICU-COVID-TR

Details and patient eligibility

About

The investigators aimed to investigate the clinical and epidemiological characteristics of neonates who will be born to Covid-19 positive mothers in Turkey. It is a multicentric prospective cohort study designed and destined only in Turkey. The investigators are planning to admit more than 20 Neonatal Intensive Care Units into the survey; nevertheless, the total number may change according to the prevalence of Covid-19 in neonates.

The investigators will also inquire into vertical transmission by collecting cord blood, placental, and postnatal serum samples to test for Covid-19 PCR and Covid-19 Ig M and IgG values from the neonates.

Full description

The patients will be recruited by a secure database of "Trials Network" with individualized accounts. Plexus Corporation will hold data monitoring and primary analysis.

Enrollment

90 estimated patients

Sex

All

Ages

Under 28 days old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Infants born to mothers with Covid-19 infection

Exclusion criteria

  • If PCR values of mother negative, even though the clinic is preferable for Covid-19, the infant will not be recruited.

Trial contacts and locations

1

Loading...

Central trial contact

Mehmet K Kanburoglu, M.D.; Mehmet Y Oncel, M.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems